• 1. Fused quinoline heterocycles I. First example of the 2,4-diazidoquinoline-3-carbonitrile and 1-aryl-1,5-dihydro-1,2,3,4,5,6-hexaazaacephenanthrylenes ring systems
  Ramadan A. Mekheimer J. Chem. Soc. Perkin Trans. 1 1999 2183
• 2. Synthesis of 4-azido-3-diazo-3H-pyrazolo[3,4-b]quinoline from 3-amino-4-hydrazino-1H-pyrazolo[3,4-b]quinoline1
  Wolfgang Stadlbauer,Gerhard Hojas J. Chem. Soc. Perkin Trans. 1 2000 3085

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Hydroquinolones
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Quinolones and derivatives Hydroquinolones
• Solvents and Organic Chemicals Organic Compounds cyanides/Cyanides

Recent Advances in the Study of 4-Hydroxyquinoline-3-carbonitrile (CAS: 2305-70-6) and Its Applications in Chemical Biology and Medicine

4-Hydroxyquinoline-3-carbonitrile (CAS: 2305-70-6) is a heterocyclic compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and medicinal chemistry. This compound, characterized by its quinoline scaffold and nitrile functional group, has been explored for its potential as a building block in the synthesis of biologically active molecules. Recent studies have highlighted its role in the development of novel therapeutic agents, particularly in the areas of antimicrobial, anticancer, and anti-inflammatory drug discovery.

One of the most notable advancements in the study of 4-Hydroxyquinoline-3-carbonitrile is its application in the design of kinase inhibitors. Kinases are critical enzymes involved in various cellular signaling pathways, and their dysregulation is often associated with diseases such as cancer and inflammatory disorders. Researchers have synthesized a series of derivatives based on the 4-Hydroxyquinoline-3-carbonitrile scaffold, demonstrating potent inhibitory activity against specific kinase targets. For instance, a recent study published in the Journal of Medicinal Chemistry reported the development of a derivative that selectively inhibits the JAK2 kinase, a key player in myeloproliferative neoplasms.

In addition to its role in kinase inhibition, 4-Hydroxyquinoline-3-carbonitrile has also been investigated for its antimicrobial properties. A 2023 study in the European Journal of Medicinal Chemistry described the synthesis of novel quinoline-carbonitrile hybrids with broad-spectrum activity against drug-resistant bacterial strains. These compounds exhibited low cytotoxicity to mammalian cells, making them promising candidates for further development as antibacterial agents. The study also provided insights into the structure-activity relationship (SAR) of these derivatives, which could guide future optimization efforts.

Another area of interest is the use of 4-Hydroxyquinoline-3-carbonitrile in the development of fluorescent probes for biological imaging. The quinoline core is known for its photophysical properties, and recent work has leveraged this feature to create probes for detecting reactive oxygen species (ROS) in live cells. A study published in Analytical Chemistry demonstrated the utility of a 4-Hydroxyquinoline-3-carbonitrile-based probe in monitoring oxidative stress in real-time, offering a valuable tool for studying redox biology and related pathologies.

Despite these promising developments, challenges remain in the optimization of 4-Hydroxyquinoline-3-carbonitrile derivatives for clinical use. Issues such as solubility, bioavailability, and off-target effects need to be addressed through further structural modifications and preclinical evaluations. Nevertheless, the compound's versatility and the growing body of research supporting its applications underscore its potential as a key player in the future of drug discovery and chemical biology.

In conclusion, 4-Hydroxyquinoline-3-carbonitrile (CAS: 2305-70-6) represents a valuable scaffold in the design of novel therapeutic agents and biological tools. Recent studies have expanded our understanding of its pharmacological potential and provided a foundation for future research. As the field continues to evolve, this compound is likely to play an increasingly important role in addressing unmet medical needs and advancing our knowledge of biological systems.

• 936345-80-1(5-hydroxy-8-Quinolinecarbonitrile)
• 848128-91-6(4-Hydroxy-8-cyanoquinoline)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)